Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2015

Open Access 01-12-2015 | Research

Perspectives of clinical microbiologists on antimicrobial stewardship programmes within NHS trusts in England

Authors: Chantelle Bailey, Mary Tully, Jonathan Cooke

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2015

Login to get access

Abstract

Background

The Antimicrobial Self-Assessment Toolkit for NHS Trusts (ASAT) was developed in England by a National Pharmacist Reference Group of an Advisory Non-Departmental Public Body on Antimicrobial Resistance and Healthcare Associated Infections (ARHAI), in conjunction with the Department of Health. It is intended to identify and evaluate interventions for the promotion and implementation hospital-based antimicrobial stewardship programmes (ASPs). ASAT v16 was produced by iterative validity testing with end-users utilising a sequential exploratory strategy. It was highlighted that there was a need for the inclusion of the domain which targeted the role of clinical microbiologists due to their substantial roles in hospital-based ASP development and implementation.

Methods

This study aimed to investigate the content validity of ASAT v16 and a proposed draft domain for clinical microbiologists and hence produce ASAT v17. From June to September 2011, semi-structured interviews were conducted with ten consultant clinical microbiologists from secondary and tertiary care National Health Service (NHS) Trusts within England. Interviews were conducted until no novel themes were identified i.e., data saturation was achieved. Each interview was digitally recorded and transcribed verbatim and then analysed using a thematic framework that facilitated the identification of emergent themes and sub-themes.

Results

Nine emergent themes were identified which included common enablers and challenges associated with the implementation of effective and sustainable hospital-based ASPs. Key themes included formal governmental mandates, IT infrastructure and also prescribers’ knowledge base of antimicrobial chemotherapy and infectious diseases. Most respondents agreed with the content of ASATv16 and the proposed draft section however they suggested that minor modifications were required to improve question sensitivity and hence reduce measurement error.

Conclusions

Although, the ASAT been through multiple iterations and content validity testing, further modifications were required to produce the next iteration, ASAT v17. Question merging and other minor modifications were conducted as indicated by study findings. This study reinforces the need for stakeholder engagement during the development and implementation of tools that evaluate hospital-based implementation strategies.
Literature
3.
go back to reference Nathwani D. Antimicrobial stewardship. In: Mayhall C, editor. Hospital epidemiology and infection control. 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 2012. Nathwani D. Antimicrobial stewardship. In: Mayhall C, editor. Hospital epidemiology and infection control. 4th ed. Philadelphia: Lippincott, Williams and Wilkins; 2012.
4.
go back to reference Davey PB, Charani E, Fenelon E, Gould IM, Holmes A, Ramsay CR, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4. Davey PB, Charani E, Fenelon E, Gould IM, Holmes A, Ramsay CR, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4.
8.
go back to reference Cooke J, Alexander K, Charani E, Hand K, Hills T, Howard P, et al. Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals. J Antimicrob Chemother. 2010;65:2669–73. doi:10.1093/jac/dkq367.CrossRefPubMed Cooke J, Alexander K, Charani E, Hand K, Hills T, Howard P, et al. Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals. J Antimicrob Chemother. 2010;65:2669–73. doi:10.​1093/​jac/​dkq367.CrossRefPubMed
9.
go back to reference Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77. doi:10.1086/510393.CrossRefPubMed Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77. doi:10.​1086/​510393.CrossRefPubMed
12.
go back to reference Bailey C, Tully M, Cooke J. An investigation into the content validity of the antimicrobial self-assessment toolkit for NHS trusts (ASAT v15a) using cognitive interviews with antimicrobial pharmacists. J Clin Pharm Ther. 2015;40:208–12. doi:10.1111/jcpt.12248.CrossRefPubMed Bailey C, Tully M, Cooke J. An investigation into the content validity of the antimicrobial self-assessment toolkit for NHS trusts (ASAT v15a) using cognitive interviews with antimicrobial pharmacists. J Clin Pharm Ther. 2015;40:208–12. doi:10.​1111/​jcpt.​12248.CrossRefPubMed
16.
20.
go back to reference Messick S. The once and future issues of validity: Assessing the meaning and consequences of validity. In: Wainer HBH, editor. Test validity. 2nd ed. New Jersey: Lawrence Erlbaum Associates Inc; 1998. p. 33–45. Messick S. The once and future issues of validity: Assessing the meaning and consequences of validity. In: Wainer HBH, editor. Test validity. 2nd ed. New Jersey: Lawrence Erlbaum Associates Inc; 1998. p. 33–45.
21.
go back to reference Streiner DN, Norman G. Health measurement scales. 4th ed. Oxford: Oxford University Press; 2008.CrossRef Streiner DN, Norman G. Health measurement scales. 4th ed. Oxford: Oxford University Press; 2008.CrossRef
22.
go back to reference DeVilles R. Scale development. 2nd ed. USA: SAGE Publications Inc.; 2003. DeVilles R. Scale development. 2nd ed. USA: SAGE Publications Inc.; 2003.
23.
go back to reference Sankar P, Jones NL. Semi-structured interviews in bioethics research. London: Emerald Group Publishing Limited; 2007.CrossRef Sankar P, Jones NL. Semi-structured interviews in bioethics research. London: Emerald Group Publishing Limited; 2007.CrossRef
24.
go back to reference Ritchie J, Lewis J. Qualitative research practice: a guide for social science students and researchers. London: SAGE Publications Inc.; 2003. Ritchie J, Lewis J. Qualitative research practice: a guide for social science students and researchers. London: SAGE Publications Inc.; 2003.
25.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a New PRO instrument. Value Health. 2011;14:967–77. doi:10.1016/j.jval.2011.06.014.CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1—eliciting concepts for a New PRO instrument. Value Health. 2011;14:967–77. doi:10.​1016/​j.​jval.​2011.​06.​014.CrossRefPubMed
26.
go back to reference Polit DF, Beck CT. Nursing research: generating and assessing evidence for nursing practice. Philadelphia: Lippincott Williams & Wilkins; 2011. Polit DF, Beck CT. Nursing research: generating and assessing evidence for nursing practice. Philadelphia: Lippincott Williams & Wilkins; 2011.
29.
go back to reference Buyle FM, Metz-Gercek S, Mechtler R, Kern WV, Robays H, Vogelaers D, et al. Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals. Eur J Clin Microbiol Infect Dis. 2013;32(9):1161–70. doi:10.1007/s10096-013-1862-4.CrossRefPubMed Buyle FM, Metz-Gercek S, Mechtler R, Kern WV, Robays H, Vogelaers D, et al. Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals. Eur J Clin Microbiol Infect Dis. 2013;32(9):1161–70. doi:10.​1007/​s10096-013-1862-4.CrossRefPubMed
31.
go back to reference Patton M. Qualitative evaluation and research methods. 3rd ed. Newbury Park: SAGE Publications Inc.; 2001. Patton M. Qualitative evaluation and research methods. 3rd ed. Newbury Park: SAGE Publications Inc.; 2001.
32.
go back to reference Cooke J, Stephens P, Ashiru-Oredope D, Charani E, Dryden M, Fry C, et al. Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008–13): working towards hospital prescribing quality measures. J Antimicrob Chemother. 2015;70:279–85. doi:10.1093/jac/dku328.CrossRefPubMed Cooke J, Stephens P, Ashiru-Oredope D, Charani E, Dryden M, Fry C, et al. Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008–13): working towards hospital prescribing quality measures. J Antimicrob Chemother. 2015;70:279–85. doi:10.​1093/​jac/​dku328.CrossRefPubMed
Metadata
Title
Perspectives of clinical microbiologists on antimicrobial stewardship programmes within NHS trusts in England
Authors
Chantelle Bailey
Mary Tully
Jonathan Cooke
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2015
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-015-0090-3

Other articles of this Issue 1/2015

Antimicrobial Resistance & Infection Control 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine